164 related articles for article (PubMed ID: 9139878)
1. Resistance to IL-1 anti-proliferative effect, accompanied by characteristics of advanced melanoma, permits invasion of human melanoma cells in vitro, but not metastasis in the nude mouse.
Hayashi H; Shimizu R; Fujii K; Itoh S; Yang D; Onozaki K
Int J Cancer; 1997 May; 71(3):416-21. PubMed ID: 9139878
[TBL] [Abstract][Full Text] [Related]
2. Interleukin 1 (IL-1) production is not essential for acquired resistance of human A375 melanoma cells to anti-proliferative effect of IL-1.
Itoh S; Hayashi H; Watanabe N; Kobayashi Y; Takii T; Onozaki K
Int J Cancer; 1996 Mar; 65(6):805-11. PubMed ID: 8631596
[TBL] [Abstract][Full Text] [Related]
3. Expression of interleukin-8 by human melanoma cells up-regulates MMP-2 activity and increases tumor growth and metastasis.
Luca M; Huang S; Gershenwald JE; Singh RK; Reich R; Bar-Eli M
Am J Pathol; 1997 Oct; 151(4):1105-13. PubMed ID: 9327744
[TBL] [Abstract][Full Text] [Related]
4. Resistance to the anti-proliferative effect of IL-1 on human melanoma cell line is associated with endogenous production of IL-1 and IL-6.
Araki M; Yano T; Hayashi H; Takii T; Suzuki K; Onozaki K
Int J Cancer; 1994 Jan; 56(2):275-80. PubMed ID: 8314311
[TBL] [Abstract][Full Text] [Related]
5. Interleukin 10 suppresses tumor growth and metastasis of human melanoma cells: potential inhibition of angiogenesis.
Huang S; Xie K; Bucana CD; Ullrich SE; Bar-Eli M
Clin Cancer Res; 1996 Dec; 2(12):1969-79. PubMed ID: 9816156
[TBL] [Abstract][Full Text] [Related]
6. Acquired resistance to the anti-proliferative effect of interleukin-1 and interleukin-6 is a recessive phenotype in A375 human melanoma cells.
Itoh S; Hayashi H; Yang D; Takii T; Onozaki K
Melanoma Res; 1997 Dec; 7(6):455-62. PubMed ID: 9464617
[TBL] [Abstract][Full Text] [Related]
7. Involvement of tumor cell integrin alpha v beta 3 in hematogenous metastasis of human melanoma cells.
Felding-Habermann B; Fransvea E; O'Toole TE; Manzuk L; Faha B; Hensler M
Clin Exp Metastasis; 2002; 19(5):427-36. PubMed ID: 12198771
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of matrix metalloproteinases in activated c-ras-Ha-transfected immortalized human keratinocytes.
Meade-Tollin LC; Boukamp P; Fusenig NE; Bowen CP; Tsang TC; Bowden GT
Br J Cancer; 1998 Mar; 77(5):724-30. PubMed ID: 9514050
[TBL] [Abstract][Full Text] [Related]
9. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN
J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
[TBL] [Abstract][Full Text] [Related]
10. Regulation of interleukin-8 expression in human melanoma cells by the organ environment.
Gutman M; Singh RK; Xie K; Bucana CD; Fidler IJ
Cancer Res; 1995 Jun; 55(11):2470-5. PubMed ID: 7758001
[TBL] [Abstract][Full Text] [Related]
11. Metastatic colorectal cancer cells induce matrix metalloproteinase release by human monocytes.
Swallow CJ; Murray MP; Guillem JG
Clin Exp Metastasis; 1996 Jan; 14(1):3-11. PubMed ID: 8521614
[TBL] [Abstract][Full Text] [Related]
12. Regulation of matrix metalloproteinases (MMP-2, -3, -9, and -13) by interleukin-1 and interleukin-6 in mouse calvaria: association of MMP induction with bone resorption.
Kusano K; Miyaura C; Inada M; Tamura T; Ito A; Nagase H; Kamoi K; Suda T
Endocrinology; 1998 Mar; 139(3):1338-45. PubMed ID: 9492070
[TBL] [Abstract][Full Text] [Related]
13. Cytokine sensitivity of metastatic human melanoma cell lines-- simultaneous inhibition of proliferation and enhancement of gelatinase activity.
Ladányi A; Nagy JO; Jeney A; Tímár J
Pathol Oncol Res; 1998; 4(2):108-14. PubMed ID: 9654595
[TBL] [Abstract][Full Text] [Related]
14. Two human melanoma cell-line variants with enhanced in vivo tumor growth and metastatic capacity do not express the beta 3 integrin subunit.
Boukerche H; Benchaibi M; Berthier-Vergnes O; Lizard G; Bailly M; Bailly M; McGregor JL
Eur J Biochem; 1994 Mar; 220(2):485-91. PubMed ID: 8125107
[TBL] [Abstract][Full Text] [Related]
15. Role of interleukin-8 in tumor growth and metastasis of human melanoma.
Bar-Eli M
Pathobiology; 1999; 67(1):12-8. PubMed ID: 9873223
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression.
Hofmann UB; Westphal JR; Waas ET; Zendman AJ; Cornelissen IM; Ruiter DJ; van Muijen GN
Br J Cancer; 1999 Nov; 81(5):774-82. PubMed ID: 10555745
[TBL] [Abstract][Full Text] [Related]
17. Intact vitronectin induces matrix metalloproteinase-2 and tissue inhibitor of metalloproteinases-2 expression and enhanced cellular invasion by melanoma cells.
Bafetti LM; Young TN; Itoh Y; Stack MS
J Biol Chem; 1998 Jan; 273(1):143-9. PubMed ID: 9417058
[TBL] [Abstract][Full Text] [Related]
18. Ultraviolet B irradiation promotes tumorigenic and metastatic properties in primary cutaneous melanoma via induction of interleukin 8.
Singh RK; Gutman M; Reich R; Bar-Eli M
Cancer Res; 1995 Aug; 55(16):3669-74. PubMed ID: 7543020
[TBL] [Abstract][Full Text] [Related]
19. Selective modulation of collagenase 1 gene expression by the chemotherapeutic agent doxorubicin.
Benbow U; Maitra R; Hamilton JW; Brinckerhoff CE
Clin Cancer Res; 1999 Jan; 5(1):203-8. PubMed ID: 9918220
[TBL] [Abstract][Full Text] [Related]
20. Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder.
Slaton JW; Karashima T; Perrotte P; Inoue K; Kim SJ; Izawa J; Kedar D; McConkey DJ; Millikan R; Sweeney P; Yoshikawa C; Shuin T; Dinney CP
Clin Cancer Res; 2001 Sep; 7(9):2840-53. PubMed ID: 11555602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
